Warning: The NCBI web site requires JavaScript to function. more...
Safety of topical thrombins: the ongoing debate.
Lomax C.
Patient Saf Surg. 2009 Sep 4;3(1):21.
Related citations
A review of three stand-alone topical thrombins for surgical hemostasis.
Cheng CM, Meyer-Massetti C, Kayser SR.
Clin Ther. 2009 Jan;31(1):32-41. Review.
Topical thrombins: benefits and risks.
Lomax C, Traub O.
Pharmacotherapy. 2009 Jul;29(7 Pt 2):8S-12S.
Topical bovine thrombin: a 21-year review of topical bovine thrombin spontaneous case safety reports submitted to FDA's Adverse Event Reporting System.
Clark JA, Humphries JE, Crean S, Reynolds MW.
Pharmacoepidemiol Drug Saf. 2010 Feb;19(2):107-14. Review.
Recent developments in topical thrombins.
Kessler CM, Ortel TL.
Thromb Haemost. 2009 Jul;102(1):15-24. Review.
Final Report on Carcinogens Background Document for Formaldehyde.
National Toxicology Program.
Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.
The clinical use and immunologic impact of thrombin in surgery.
Lawson JH.
Semin Thromb Hemost. 2006 Apr;32 Suppl 1:98-110. Review.
A safety review of topical bovine thrombin-induced generation of antibodies to bovine proteins.
Ofosu FA, Crean S, Reynolds MW.
Clin Ther. 2009 Apr;31(4):679-91. Review.
Clinical use of topical thrombin as a surgical hemostat.
Lew WK, Weaver FA.
Biologics. 2008 Dec;2(4):593-9.
Thrombin products: economic impact of immune-mediated coagulopathies and practical formulary considerations.
Voils SA.
Pharmacotherapy. 2009 Jul;29(7 Pt 2):18S-22S.
Inside the black box: current policies and concerns with the United States Food and Drug Administration's highest drug safety warning system.
Halloran K, Barash PG.
Curr Opin Anaesthesiol. 2010 Jun;23(3):423-7. Review.
Final Report on Carcinogens Background Document for Styrene.
Rep Carcinog Backgr Doc. 2008 Sep;(8-5978):i-398.
Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
[No authors listed]
CMAJ. 1995 Jul 15;153(2):147-57.
Topical use of recombinant human thrombin for operative hemostasis.
Anderson CD, Bowman LJ, Chapman WC.
Expert Opin Biol Ther. 2009 Jan;9(1):133-7. Review.
A phase 3, randomized, double-blind comparative study of the efficacy and safety of topical recombinant human thrombin and bovine thrombin in surgical hemostasis.
Chapman WC, Singla N, Genyk Y, McNeil JW, Renkens KL Jr, Reynolds TC, Murphy A, Weaver FA.
J Am Coll Surg. 2007 Aug;205(2):256-65. Epub 2007 Jun 27.
Comparison of recombinant human thrombin and plasma-derived human alpha-thrombin.
Bishop PD, Lewis KB, Schultz J, Walker KM.
Semin Thromb Hemost. 2006 Apr;32 Suppl 1:86-97. Review.
A comparison of recombinant thrombin to bovine thrombin as a hemostatic ancillary in patients undergoing peripheral arterial bypass and arteriovenous graft procedures.
Weaver FA, Lew W, Granke K, Yonehiro L, Delange B, Alexander WA; Study Investigators.
J Vasc Surg. 2008 Jun;47(6):1266-73. Epub 2008 Apr 28.
Whole blood thrombin: development of a process for intra-operative production of human thrombin.
Kumar V, Chapman JR.
J Extra Corpor Technol. 2007 Mar;39(1):18-23.
Serological analysis of patients treated with a new surgical hemostat containing bovine proteins and autologous plasma.
Nelson PA, Powers JN, Estridge TD, Elder EA, Alea AD, Sidhu PK, Sehl LC, DeLustro FA.
J Biomed Mater Res. 2001;58(6):710-9.
Preclinical safety of recombinant human thrombin.
Heffernan JK, Ponce RA, Zuckerman LA, Volpone JP, Visich J, Giste EE, Jenkins N, Boster D, Pederson S, Knitter G, Palmer T, Wills M, Early RJ, Rogge MC.
Regul Toxicol Pharmacol. 2007 Feb;47(1):48-58. Epub 2006 Sep 12.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on